| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,330 | 15,341 | 11,061 | 16,428 | | Cost of Revenue | 13,857 | 9,935 | 8,777 | 22,418 | | | Gross Profit | 9,473 | 5,406 | 2,284 | (5,990) | | | Operating Expenses | | Research Development | 6,427 | 6,022 | 6,743 | 7,062 | | Selling General and Administrative | 8,279 | 7,815 | 6,334 | 6,431 | | Non Recurring |
-
|
-
|
-
| 227,105 | | Others | 370 | 286 | 289 | 762 | | | | Total Operating Expenses |
-
|
-
|
-
| 241,360 | | | | Operating Income or Loss | (5,603) | (8,717) | (11,082) | (247,350) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | 48 | 124 | 304 | | Earnings Before Interest And Taxes | (5,574) | (8,669) | (10,958) | (247,046) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,574) | (8,669) | (10,958) | (247,046) | | Income Tax Expense | (739) | (44) | (904) | (1,439) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,835) | (8,625) | (10,054) | (245,607) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,835) | (8,625) | (10,054) | (245,607) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,835) | ($8,625) | ($10,054) | ($245,607) |
|
0.01% Nasdaq 
Income Statement
